Introduction <p>Owing to its safety and success rate, cochlear implants have received widespread acknowledgment and acceptance amongst patients suffering from sensorineural hearing loss. However, this technique is not free of complications. Cholesteatoma is one such rare, delayed complication. This iatrogenically produced complication is ultimately left with surgery as its only treatment modality.</p> Case Report <p>Here, we present the case of a 4 year old post-implanted patient who presented with chronic ear discharge 2 years after cochlear implantation, underwent surgical exploration which led us to find squamous epithelium (cholesteatoma) in the middle ear cleft and encasing the implant. Disease was removed keeping implant in-situ and posterior canal wall was repaired, thus ensuring the patient good post-operative recovery and hearing through intact cochlear implant.</p> Conclusion <p>Cholesteatoma is a rare delayed complication of cochlear implantation, often iatrogenic in origin. Surgical management remains the definitive treatment, and the approach should be tailored to disease extent and clinical presentation. Individualised surgery helps minimise postoperative morbidity and preserves the long-term benefits of both residual hearing and cochlear implant function.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

When Hearing Restored Meets a Silent Invader: A Child with Post-implant Cholesteatoma

  • Sushmitha Nagaraj,
  • Pawan Singhal,
  • Eshita Bansal,
  • Junior Resident,
  • Saurav Kamat,
  • Kailash Singh Jat,
  • Siddharth Nirwan

摘要

Introduction

Owing to its safety and success rate, cochlear implants have received widespread acknowledgment and acceptance amongst patients suffering from sensorineural hearing loss. However, this technique is not free of complications. Cholesteatoma is one such rare, delayed complication. This iatrogenically produced complication is ultimately left with surgery as its only treatment modality.

Case Report

Here, we present the case of a 4 year old post-implanted patient who presented with chronic ear discharge 2 years after cochlear implantation, underwent surgical exploration which led us to find squamous epithelium (cholesteatoma) in the middle ear cleft and encasing the implant. Disease was removed keeping implant in-situ and posterior canal wall was repaired, thus ensuring the patient good post-operative recovery and hearing through intact cochlear implant.

Conclusion

Cholesteatoma is a rare delayed complication of cochlear implantation, often iatrogenic in origin. Surgical management remains the definitive treatment, and the approach should be tailored to disease extent and clinical presentation. Individualised surgery helps minimise postoperative morbidity and preserves the long-term benefits of both residual hearing and cochlear implant function.